Clinical Trial Update: Aggrenox Prevention of Access Stenosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Aggrenox in preventing access stenosis, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Failure

Drugs mentioned

• Aggrenox (aspirin and dipyridamole)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Kidney Failure | Phase 3 | Status: COMPLETED